See more : PT Darma Henwa Tbk (DEWA.JK) Income Statement Analysis – Financial Results
Complete financial analysis of Hero Technologies Inc. (HENC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Hero Technologies Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Svenska Handelsbanken AB (publ) (SHB-B.ST) Income Statement Analysis – Financial Results
- Investcorp India Acquisition Corp (IVCAW) Income Statement Analysis – Financial Results
- Ultra Chip, Inc. (3141.TWO) Income Statement Analysis – Financial Results
- Wegener Corporation (WGNR) Income Statement Analysis – Financial Results
- Intec Capital Limited (INTECCAP.BO) Income Statement Analysis – Financial Results
Hero Technologies Inc. (HENC)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://herotechnologiesinc.com
About Hero Technologies Inc.
Hero Technologies Inc. operates as an early-stage cannabis company. It focuses on the provision of BlackBox, an aeroponic cannabis cultivation system that provides optimal growing conditions to enhance photosynthesis and the cultivation of large flowering plants and create increased harvest efficiencies. The company also intends to offer cannabis genetic engineering farmland for medical and recreational cannabis cultivation, production, distribution, packaging, and retail operations, as well as for dispensaries. The company was incorporated in 2004 and is headquartered in Dover, Delaware.
Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 1.53K | 197.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 495.78K | 40.09K | 0.00 | 0.00 | 0.00 | 58.96K | 0.00 | 0.00 |
Cost of Revenue | 1.98K | 72.69K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.64M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | -1.98K | -71.16K | 197.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.64M | 0.00 | 0.00 | 495.78K | 40.09K | 0.00 | 0.00 | 0.00 | 58.96K | 0.00 | 0.00 |
Gross Profit Ratio | 0.00% | -4,666.30% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 0.00% | 0.00% | 0.00% | 100.00% | 0.00% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 505.00K | 1.17M | 5.78M | 74.37K | 0.00 | 0.00 | 228.09K | 441.79K | 345.99K | 415.71K | 997.52K | 555.89K | 1.84M | 2.14M | 167.03K | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 620.00 | 0.00 | 0.00 | 117.98K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 881.73K | 0.00 | 0.00 | 0.00 |
SG&A | 505.62K | 1.17M | 5.78M | 118.05K | 146.09K | 133.68K | 228.09K | 441.79K | 345.99K | 415.71K | 997.52K | 555.89K | 1.84M | 2.14M | 1.05M | 1.33M | 28.20K | 20.08K |
Other Expenses | 0.00 | 2.05K | 0.00 | 0.00 | 0.00 | 0.00 | 229.40K | 0.00 | 0.00 | 0.00 | 3.40K | 6.81K | 625.73K | 0.00 | 0.00 | 47.42K | 0.00 | 0.00 |
Operating Expenses | 505.62K | 1.17M | 5.78M | 118.05K | 146.09K | 133.68K | 228.09K | 441.79K | 345.99K | 415.71K | 1.00M | 562.70K | 2.47M | 2.14M | 1.05M | 1.38M | 28.20K | 20.08K |
Cost & Expenses | 507.60K | 1.24M | 5.78M | 118.05K | 146.09K | 133.68K | 228.09K | 441.79K | 345.99K | 415.71K | 1.00M | 562.70K | 2.47M | 2.14M | 1.05M | 1.38M | 28.20K | 20.08K |
Interest Income | 183.00 | 46.96 | 58.90 | 53.75 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.28K | 0.00 | 0.00 |
Interest Expense | 60.41K | 46.96K | 58.90K | 53.75K | 52.35K | 52.86K | 50.38K | 8.20K | 6.10K | 44.65K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 132.38K | 0.00 | 0.00 |
Depreciation & Amortization | 1.98K | 2.05K | 5.78M | 87.82K | 161.14K | 52.52K | 225.38K | -1.23M | 345.99 | 746.67K | -298.79K | -40.09K | 0.00 | 8.75M | -898.26K | 47.42K | 0.00 | 0.00 |
EBITDA | -505.43K | -3.46M | -180.53K | -12.78M | 18.01K | -79.25K | 1.32K | -1.68M | 35.78K | 330.96K | -603.63K | -602.79K | -2.47M | -8.65M | -1.91M | -673.00K | -1.37M | -20.08K |
EBITDA Ratio | 0.00% | -226,757.77% | -2,932,689.85% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -282.02% | -1,503.44% | 0.00% | 0.00% | 0.00% | -1,814.01% | 0.00% | 0.00% |
Operating Income | -507.60K | -3.46M | -5.78M | -118.05K | -146.09K | -133.68K | -228.09K | -441.79K | 41.87K | -415.71K | -1.10M | -562.70K | -2.47M | -2.14M | -1.01M | -1.47M | -28.20K | -20.08K |
Operating Income Ratio | 0.00% | -226,892.07% | -2,932,689.85% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -221.75% | -1,403.44% | 0.00% | 0.00% | 0.00% | -2,495.52% | 0.00% | 0.00% |
Total Other Income/Expenses | -60.23K | -2.27M | -180.53K | -12.75M | 111.76K | 1.57K | 175.01K | -1.24M | 0.00 | 702.02K | 0.00 | 0.00 | 0.00 | -8.75M | 1.00 | 564.12K | -1.43M | 0.00 |
Income Before Tax | -567.83K | -3.51M | -5.96M | -12.87M | -34.34K | -132.11K | -53.08K | -1.68M | 35.78K | 286.31K | -603.63K | -522.60K | -2.47M | -10.89M | -282.52K | -1.51M | -28.20K | -20.08K |
Income Before Tax Ratio | 0.00% | -230,357.31% | -3,024,328.43% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -121.75% | -1,303.44% | 0.00% | 0.00% | 0.00% | -2,557.36% | 0.00% | 0.00% |
Income Tax Expense | 0.00 | -2.26M | 58.90K | -87.81 | -161.14K | -52.52K | 37.68K | 37.92K | -288.06K | 828.58K | -98.49K | 522.60K | 0.00 | -2.24M | -1.09M | 1.51M | 28.20K | 20.08K |
Net Income | -541.58K | -1.25M | -6.02M | -12.87M | -34.34K | -132.11K | -90.76K | -1.72M | 323.84K | -542.27K | -603.63K | -522.60K | -2.47M | -8.65M | 808.32K | -1.51M | -28.20K | -20.08K |
Net Income Ratio | 0.00% | -81,849.38% | -3,054,224.87% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -121.75% | -1,303.44% | 0.00% | 0.00% | 0.00% | -2,557.36% | 0.00% | 0.00% |
EPS | 0.00 | 0.00 | -0.04 | -0.09 | 0.00 | 0.00 | 0.00 | -0.02 | 0.00 | 0.00 | -0.01 | 0.00 | -0.02 | -0.09 | 0.01 | -0.02 | 0.00 | 0.00 |
EPS Diluted | 0.00 | 0.00 | -0.04 | -0.09 | 0.00 | 0.00 | 0.00 | -0.02 | 0.00 | 0.00 | -0.01 | 0.00 | -0.02 | -0.09 | 0.01 | -0.02 | 0.00 | 0.00 |
Weighted Avg Shares Out | 447.96M | 430.07M | 154.88M | 143.69M | 136.00M | 125.19M | 115.32M | 112.64M | 111.02M | 110.33M | 109.78M | 108.57M | 107.24M | 100.84M | 85.86M | 63.74M | 59.42M | 43.99M |
Weighted Avg Shares Out (Dil) | 447.59M | 430.07M | 154.88M | 143.69M | 136.00M | 125.19M | 115.32M | 112.64M | 111.02M | 110.33M | 109.78M | 108.57M | 107.24M | 100.84M | 85.86M | 63.74M | 59.42M | 43.99M |
Hero Technologies Receives Independent Valuation and Purchase Price Allocation for Veteran Hemp Co. Acquisition
Hero Technologies Leadership Continues Holding Shares, Supporting Shareholder Value; Company Management and Insiders Reiterate Transparent, Anti-Dilutive Approach
Hero Technologies' Subsidiary Receives Zoning Approval for Cannabis Cultivation on 120-Acre Michigan Property Planned for Purchase
Hero Technologies' Subsidiary Receives Zoning Approval for Cannabis Cultivation on 120-Acre Michigan Property Planned for Purchase
HENC Projects Multi-Billion Dollar Cannabis Operation in Michigan; Revenue Analysis of Multi-Phase Cultivation Plan Shows $3 billion Upside Potential in Annual Retail Value
HENC Unveils New Website; Fast-growing Cannabis Company Redesigns Site to Feature Expanding Brands and Assets
Hero Technologies' Subsidiary Completes Appraisal and Survey of Michigan Cannabis Property Planned for Purchase
Hero Technologies to Buy 40 Acres of Land in Colorado - One of America's Top Cannabis Markets
Hero Technologies Forms Subsidiary for Massachusetts Acquisitions; Total Massachusetts Cannabis Sales Surpassed $1 Billion in 2020-Market Growing Fast
Hero Technologies Launches New Website, Social Media Channels; Engages Chesapeake Group for Investor Relations
Source: https://incomestatements.info
Category: Stock Reports